Fabio Fiordaliso1, Giacomo Clerici2, Serena Maggioni3, Maurizio Caminiti2, Cinzia Bisighini3, Deborah Novelli3, Daniela Minnella2, Alessandro Corbelli3, Riccardo Morisi4, Alberto De Iaco5, Ezio Faglia2. 1. Unit of Bio-Imaging, Department of Cardiovascular Research, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Via La Masa 19, 20156, Milan, Italy. fabio.fiordaliso@marionegri.it. 2. Diabetic Foot Center, IRCCS MultiMedica, Sesto San Giovanni, Milan, Italy. 3. Unit of Bio-Imaging, Department of Cardiovascular Research, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Via La Masa 19, 20156, Milan, Italy. 4. Department of Orthopedics, IRCCS MultiMedica, Sesto San Giovanni, Milan, Italy. 5. Department of Ophthalmology, IRCCS MultiMedica, Sesto San Giovanni, Milan, Italy.
Abstract
AIMS/HYPOTHESIS: We investigated the significance of microangiopathy in the development of foot ulcer, which is still disputed. METHODS: We assessed microangiopathy by histological analysis of the capillary ultrastructure using transmission electron microscopy and capillary density and arteriolar morphology in paraffin-embedded sections from the skin of type 2 diabetic patients: 30 neuroischaemic patients (Isc) revascularised with peripheral angioplasty and 30 neuropathic patients (Neu) with foot ulcer, compared with ten non-diabetic volunteers. RESULTS: In the diabetic patients, capillaries in the dermal papillary layer were fewer (-22.2%, 159 ± 43 vs 205 ± 52 mm(2) in non-diabetic volunteers, p < 0.01). They also showed detrimental remodelling, with a 2.2-fold increase in capillary basement membrane thickness (3.44 ± 1.19 vs 1.53 ± 0.34 μm in non-diabetic volunteers, p < 0.001) and a 57.7% decrease in lumen area (14.6 ± 11.1 vs 34.7 ± 27.5 μm(2), p < 0.001). No differences were observed between the diabetic Isc or Neu patients. Isc were more prone to develop arteriolar occlusion than Neu (16.8 ± 6.9% vs 6.7 ± 3.7%, respectively, p < 0.001). No patient had been amputated at 30 days and healing time was significantly longer in Isc (180 ± 120 vs 64 ± 50 days in Neu, p < 0.001). CONCLUSIONS/ INTERPRETATION: Capillary microangiopathy is present in equal measure in neuroischaemic and neuropathic diabetic foot skin. The predominance of arteriolar occlusions with neuroischaemia indicated the existence of an additional 'small vessel disease' that did not affect an effective revascularisation and did not worsen the prognosis of major amputations but slowed the healing process of the neuroischaemic foot ulcer. TRIAL REGISTRATION: ClinicalTrials.gov NCT02610036.
AIMS/HYPOTHESIS: We investigated the significance of microangiopathy in the development of foot ulcer, which is still disputed. METHODS: We assessed microangiopathy by histological analysis of the capillary ultrastructure using transmission electron microscopy and capillary density and arteriolar morphology in paraffin-embedded sections from the skin of type 2 diabeticpatients: 30 neuroischaemic patients (Isc) revascularised with peripheral angioplasty and 30 neuropathicpatients (Neu) with foot ulcer, compared with ten non-diabetic volunteers. RESULTS: In the diabeticpatients, capillaries in the dermal papillary layer were fewer (-22.2%, 159 ± 43 vs 205 ± 52 mm(2) in non-diabetic volunteers, p < 0.01). They also showed detrimental remodelling, with a 2.2-fold increase in capillary basement membrane thickness (3.44 ± 1.19 vs 1.53 ± 0.34 μm in non-diabetic volunteers, p < 0.001) and a 57.7% decrease in lumen area (14.6 ± 11.1 vs 34.7 ± 27.5 μm(2), p < 0.001). No differences were observed between the diabetic Isc or Neupatients. Isc were more prone to develop arteriolar occlusion than Neu (16.8 ± 6.9% vs 6.7 ± 3.7%, respectively, p < 0.001). No patient had been amputated at 30 days and healing time was significantly longer in Isc (180 ± 120 vs 64 ± 50 days in Neu, p < 0.001). CONCLUSIONS/ INTERPRETATION:Capillary microangiopathy is present in equal measure in neuroischaemic and neuropathic diabetic foot skin. The predominance of arteriolar occlusions with neuroischaemia indicated the existence of an additional 'small vessel disease' that did not affect an effective revascularisation and did not worsen the prognosis of major amputations but slowed the healing process of the neuroischaemic foot ulcer. TRIAL REGISTRATION: ClinicalTrials.gov NCT02610036.
Authors: E Faglia; G Clerici; J Clerissi; M Mantero; M Caminiti; A Quarantiello; V Curci; T Lupattelli; A Morabito Journal: Diabet Med Date: 2007-06-08 Impact factor: 4.359
Authors: Raelina S Howell; Theresa Criscitelli; Jon S Woods; Brian M Gillette; Harold Brem; Scott Gorenstein Journal: AORN J Date: 2018-04 Impact factor: 0.676
Authors: Rutger C Lalieu; Robin J Brouwer; Dirk T Ubbink; Rigo Hoencamp; René Bol Raap; Rob A van Hulst Journal: Wound Repair Regen Date: 2019-11-26 Impact factor: 3.401
Authors: Martin Pfister; Hannes Stegmann; Kornelia Schützenberger; Bhavapriya Jasmin Schäfer; Christine Hohenadl; Leopold Schmetterer; Martin Gröschl; René M Werkmeister Journal: Ann N Y Acad Sci Date: 2021-02-26 Impact factor: 5.691